Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-22

Clinical Trial Update: Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of Prapchompoothaweep Remedy with loratadine for allergic rhinitis and associated adverse events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loratadine (Loratadine)
  • Prapchompoothaweep Remedy

Snippet

Sponsor: Thammasat University | Conditions: Allergic Rhinitis, Adverse Drug Event | Phase 2 | Status: COMPLETED